Nicholas Cappuccino | Vice-President, Head of Quality and Scientific Affairs
Dr Reddy's Laboratories

Nicholas Cappuccino, Vice-President, Head of Quality and Scientific Affairs, Dr Reddy's Laboratories

Dr. Cappuccino is currently the Vice-President and Head of Quality and Scientific Affairs for Dr. Reddy’s Laboratories Inc., located in Princeton, NJ, USA.Dr. Cappuccino also served as the Chief Executive Officer of Pharmaceutical Intellectual Resource Services LLC, in Lambertville, NJ USA. Prior to these positions, Dr. Cappuccino was the Chief Scientific Officer of Eagle Pharmaceuticals Inc. in Woodcliff Lake, New Jersey, USA.

Dr. Cappuccino was formerly the Executive Vice-President, Chief Scientific and Technical Officer of Andrx Pharmaceuticals and Watson Laboratories in Weston, Florida. Prior to Andrx, Dr. Cappuccino was the Vice-President of Research and Development and a member of the Executive Management Committee for Sandoz Inc. in Princeton, NJ. Prior to joining Sandoz he was Vice-President of R&D for Apotex, Inc., Toronto, Canada, responsible for world-wide generic drug development at Apotex.

He has also worked for Geneva Pharmaceuticals in Broomfield, Colorado, Hoechst-Roussel Pharmaceuticals, in Bridgewater, NJ, and Schering-Plough Corporation in Bloomfield, NJ during his 35+ year career in the pharmaceutical industry.Dr. Cappuccino currently serves as the Chair of the Science Committee for the International Generic and Biosimilar Medicines Association (IGBA) and represents IGBA on the ICH Assembly, the Regulatory Harmonization Steering Committee of Asia Pacific Economic Cooperation (APEC) and as an Industry Observer on the World Health Organization Expert Committee on Specifications for Pharmaceutical Preparations.

Nick has been a member of the ICH Quality Implementation Working Group (QIWG) and ICH Expert Working Groups for Stability (Q1A-F), Impurities (Q3A/3B), and Pharmaceutical Development (Q8). He is currently a member of the ICH Q12 EWG. He is a member of the American Association of Pharmaceutical Scientists, the Drug Information Association, and the American Chemical Society. Dr. Cappuccino is a member of the Editorial Board of the Journal of Generic Medicines. Dr. Cappuccino was elected in the spring of 2010 to serve on the USP “Monographs-Small Molecules 3” Expert Committee for the term of 2010-2015.Dr. Cappuccino holds a Ph.D. in Organic Chemistry along with MS and BS degrees from Stevens Institute of Technology,


Biosimilars Day 1 - Tuesday 31st October 2017 @ 14:30

Global quality and compliance: Threats and opportunities for increased access to medicines

back to speakers